Mary Carlson, MS CCC-SLP - Speech-Language Pathologist in Belmar, NJ

Mary Carlson, MS CCC-SLP is a Speech-language Pathologist based in Belmar, New Jersey. Mary Carlson is licensed to practice in New Jersey (license number 41YS00879700) and her current practice location is 300 C St, Belmar, New Jersey. She can be reached at her office (for appointments etc.) via phone at (973) 868-5216.

NPI number for Mary Carlson is 1215475751 and her current mailing address is 300 C St, Belmar, New Jersey. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1215475751.

Contact Information

Mary Carlson, MS CCC-SLP
300 C St,
Belmar, NJ 07719-2122
(973) 868-5216
Not Available



Healthcare Provider's Profile

Full NameMary Carlson
GenderFemale
SpecialitySpeech-language Pathologist
Location300 C St, Belmar, New Jersey
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1215475751
  • Provider Enumeration Date: 02/04/2017
  • Last Update Date: 02/04/2017

Medical Identifiers

Medical identifiers for Mary Carlson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1215475751NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 41YS00879700 (New Jersey)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mary Carlson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mary Carlson, MS CCC-SLP
300 C St,
Belmar, NJ 07719-2122

Ph: (973) 868-5216
Mary Carlson, MS CCC-SLP
300 C St,
Belmar, NJ 07719-2122

Ph: (973) 868-5216

News Archive

Scientific conference on considerations for NBCD regulatory approval pathway

The U.S. Food and Drug Administration (FDA) is currently working toward implementing the Biologics Price Competition and Innovation Act (BPCI) of 2009, which establishes an abbreviated approval pathway for biological products that are demonstrated to be "highly similar" to or "interchangeable" with a drug regulated under the Public Health Service Act.

Study finds clear link between clinic accessibility and emergency room visits

David Jones, a graduate student in the University of Alberta's School of Public Health, along with Linda Carroll, professor in the School of Public Health, and Leonard Frank, executive director of the Leduc Beaumont Devon Primary Care Network, recently completed a study that examined whether or not there was a clear association between the number of visits to the emergency department and the availability of an after-hours care clinic in Leduc, Alberta.

BioTek to be Awarded 2015 Governor's Excellence in Worksite Wellness

Continuing a proud tradition, BioTek Instruments will receive the 2015 Governor's Excellence in Worksite Wellness Award, presented by the Governor's Council on Physical Fitness and Sports.

GenoMed adds to management team

GenoMed, Inc., a Next Generation Disease Managementâ„¢ company that uses its expertise in genes to improve patient outcomes, said today that it has hired three additional full-time employees: a Chief Financial Officer, a Vice President for Marketing, and a Chief Technical Officer.

Research: ACOT7 enzyme keeps neurons' fat levels under control

We're all fatheads. That is, our brain cells are packed with fat molecules, more of them than almost any other cell type. Still, if the brain cells' fat content gets too high, they'll be in trouble. In a recent study in mice, researchers at Johns Hopkins pinpointed an enzyme that keeps neurons' fat levels under control, and may be implicated in human neurological diseases.

Read more News

› Verified 4 days ago


Speech-Language Pathologist in Belmar, NJ

Eleanor Tier,
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 508 10th Ave, Belmar, NJ 07719
Phone: 908-670-6695    Fax: 732-894-3475
Allison Lebovitz,
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 508 10th Ave, Belmar, NJ 07719
Phone: 732-910-9196    
Danielle Castellano,
Speech-Language Pathologist
Medicare: Accepting Medicare Assignments
Practice Location: 508 10th Ave, Belmar, NJ 07719
Phone: 732-910-9196    
Marissa Bianco,
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 508 10th Ave, Belmar, NJ 07719
Phone: 732-910-9196    
Taylor Dino,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 508 10th Ave, Belmar, NJ 07719
Phone: 732-910-9196    
Julianne Minutillo, M.S. ED., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 212 13th Ave, Belmar, NJ 07719
Phone: 908-331-3948    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.